Accounting for 4% of all cases, kidney cancer is currently the sixth most common cancer diagnosed in the […]
Category: News
Early-stage endometriosis now visible through non-invasive imaging
Phase 2 trial reveals significant improvement in MASH patients
Inebilizumab shows sound efficacy in landmark research
Innovative antibody discovery could lead to new Parkinson’s treatments
Phase 3 research suggests a significant leap forward in myeloma management
Extended phase 2 study highlights macrophage cell therapy’s efficacy
Collaboration yields promising Barriolide therapy Enterothelin
Positive clinical data from phase 1 study presented at ASCO annual meeting
Bone cancer affects more than 150,000 people in the UK and is often resistant to chemotherapy